Intestinal CART is a regulator of GIP and GLP-1 secretion and expression

L. Shcherbina, A. Lindqvist, A. H. Thorén Fischer, E. Ahlqvist, E. Zhang, S. E. Falkmer, E. Renström, J. Koffert, H. Honka, N. Wierup

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskriftPeer review

4 Citeringar (SciVal)

Sammanfattning

Impaired incretin effect is a culprit in Type 2 Diabetes. Cocaine- and amphetamine-regulated transcript (CART) is a regulatory peptide controlling pancreatic islet hormone secretion and beta-cell survival. Here we studied the potential expression of CART in enteroendocrine cells and examined the role of CART as a regulator of incretin secretion and expression. CART expression was found in glucose-dependent insulinotropic polypeptide (GIP)-producing K-cells and glucagon-like peptide-1 (GLP-1)-producing L-cells in human duodenum and jejunum and circulating CART levels were increased 60 min after a meal in humans. CART expression was increased by fatty acids and GIP, but unaffected by glucose in GLUTag and STC-1 cells. Exogenous CART had no effect on GIP and GLP-1 expression and secretion in GLUTag or STC-1 cells, but siRNA-mediated silencing of CART reduced GLP-1 expression and secretion. Furthermore, acute intravenous administration of CART increased GIP and GLP-1 secretion during an oral glucose-tolerance test in mice. We conclude that CART is a novel constituent of human K- and L-cells with stimulatory actions on incretin secretion and that interfering with the CART system may be a therapeutic avenue for T2D.

Originalspråkengelska
Sidor (från-till)8-16
TidskriftMolecular and Cellular Endocrinology
Volym476
Tidigt onlinedatum2018 apr 6
DOI
StatusPublished - 2018

Ämnesklassifikation (UKÄ)

  • Endokrinologi och diabetes

Fingeravtryck

Utforska forskningsämnen för ”Intestinal CART is a regulator of GIP and GLP-1 secretion and expression”. Tillsammans bildar de ett unikt fingeravtryck.

Citera det här